Loading quotes...
Discussions in the community
There is no discussion about this asset yet.
Start discussionCore data
| Name | L&G Pharma Breakthrough UCITS ETF USD - ACC |
| Issuer | L&G |
| Fund domicile | Ireland |
| TER | 0.49% |
| Fund size | €22.01m |
| P/E ratio | 16.78 |
| P/B ratio | 3.44 |
| Inception date | 23/01/2018 |
| Website |
Deep Dive
Ticker symbols
| Exchange | Symbol |
|---|---|
XETRA | ETLI.DE |
London Stock Exchange | BIGT.L |
London Stock Exchange | BIOT.L |
Amsterdam | BIOT.AS |
Frankfurt | ETLI.F |
Düsseldorf | ETLI.DU |
London | BIGT.L |
Milan | BIOT.MI |
München | ETLI.MU |
SIX | BIOT.SW |
Hamburg | ETLI.HM |
Composition
| Holdings | Share |
|---|---|
| 4.96% | |
| 3.84% | |
| 3.54% | |
| 3.08% | |
| 2.95% | |
| 2.92% | |
| 2.89% | |
| 2.79% | |
| 2.75% | |
| 2.75% |
As of 16/11/2026
Top sectors
| Sector | Share |
|---|---|
Health Care | 81.17% |
Materials | 5.52% |
Top countries
| Country | Share |
|---|---|
USA | 67.05% |
Japan | 10.43% |
Denmark | 2.98% |
United Kingdom | 2.73% |
Switzerland | 2.69% |
Italy | 2.64% |
Sweden | 2.47% |
South Korea | 2.43% |
France | 2.34% |
China | 2.14% |